Positions

Selected Publications

Academic Article

Year Title Altmetric
2020 c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae.  Nature Communications.  11. 2020
2019 Oxylipins mediate cell-to-cell communication in Pseudomonas aeruginosa.  Communications Biology.  2. 2019
2018 A simple cell-based high throughput screening (HTS) assay for inhibitors of Salmonella enterica RNA polymerase containing the general stress response regulator RpoS (σ S ).  Journal of Microbiological Methods.  150:1-4. 2018
2016 Oxylipins produced by Pseudomonas aeruginosa promote biofilm formation and virulence.  Nature Communications.  7. 2016
2016 A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease.  Virology.  496:77-89. 2016
2016 CTXϕ: Exploring new alternatives in host factor-mediated filamentous phage replications..  Bacteriophage.  6:e1128512. 2016
2016 Pf filamentous phage requires UvrD for replication in Pseudomonas aeruginosa.  Clinical and Vaccine Immunology.  1. 2016
2016 Tanzawaic acids, a chemically novel set of bacterial conjugation inhibitors.  PLoS One.  11. 2016
2015 Intracellular Degradable Hydrogel Cubes and Spheres for Anti-Cancer Drug Delivery.  ACS Applied Materials and Interfaces.  7:13633-13644. 2015
2015 Synthetic fatty acids prevent plasmid-mediated horizontal gene transfer.  mBio.  6. 2015
2014 PH-responsive hydrogel cubes for release of doxorubicin in cancer cells.  Journal of Materials Chemistry B.  2:2494-2507. 2014
2013 Biocompatible shaped particles from dried multilayer polymer capsules.  Biomacromolecules.  14:3830-3841. 2013
2011 Characterization of the single-stranded DNA binding protein pV(VGJΦ) of VGJΦ phage from Vibrio cholerae. 2011
2011 Cys mutants in functional regions of Sticholysin I clarify the participation of these residues in pore formation..  Toxicon.  58:8-17. 2011
2011 Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxins. 2011
2010 VEJ{phi}, a novel filamentous phage of Vibrio cholerae able to transduce the cholera toxin genes..  Microbiology.  156:108-115. 2010
2009 DNA binding proteins of the filamentous phages CTXphi and VGJphi of Vibrio cholerae..  Journal of Bacteriology.  191:5873-5876. 2009
2009 Anaerobic growth promotes synthesis of colonization factors encoded at the Vibrio pathogenicity island in Vibrio cholerae El Tor..  Research in Microbiology.  160:48-56. 2009
2008 El Tor and Calcutta CTXPhi precursors coexisting with intact CTXPhi copies in Vibrio cholerae O139 isolates..  Research in Microbiology.  159:81-87. 2008
2006 Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus..  Toxicon.  48:1083-1094. 2006
2005 The single-stranded genome of phage CTX is the form used for integration into the genome of Vibrio cholerae..  Molecular Cell.  19:559-566. 2005
2005 The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers..  Infection and Immunity.  73:3018-3024. 2005
2003 Novel type of specialized transduction for CTX phi or its satellite phage RS1 mediated by filamentous phage VGJ phi in Vibrio cholerae..  Journal of Bacteriology.  185:7231-7240. 2003
2003 Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae..  Hybridoma.  22:315-320. 2003
2003 VGJ phi, a novel filamentous phage of Vibrio cholerae, integrates into the same chromosomal site as CTX phi..  Journal of Bacteriology.  185:5685-5696. 2003
2003 Construction and characterisation of O139 cholera vaccine candidates..  Vaccine.  21:1282-1291. 2003
2001 Differential interleukin-8 response of intestinal epithelial cell line to reactogenic and nonreactogenic candidate vaccine strains of Vibrio cholerae..  Infection and Immunity.  69:613-616. 2001
2000 Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638..  Infection and Immunity.  68:6411-6418. 2000
1999 Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate..  Infection and Immunity.  67:539-545. 1999
1998 Replicating function of the RS1 element associated with Vibrio cholerae CTX phi prophage..  FEMS Microbiology Letters.  164:141-147. 1998
1998 Production and characterization of a monoclonal antibody against mannose-sensitive hemagglutinin of Vibrio cholerae..  Hybridoma.  17:63-67. 1998
1997 Promoter activities in Vibrio cholerae ctx phi prophage..  Infection and Immunity.  65:1561-1565. 1997
1996 Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A..  Vaccine.  14:1517-1522. 1996
1996 Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains..  Archives of Medical Research.  27:275-283. 1996

Full Name

  • Javier Campos-Gomez